Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Haizheng Pharmaceutical—officially known as Zhejiang Hisun Pharmaceutical—is one of China’s largest pharmaceutical companies with a global presence. The company has a broad commercial portfolio including APIs and finished dosage forms across anti-infective, cardiovascular, oncology, CNS disorders, animal health and more. Its biologics division produces biosimilars and innovative drugs such as monoclonal antibodies and antibody-drug conjugates. The company operates multiple GMP-compliant manufacturing sites serving over 60 countries[5][6][8].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Haizheng Pharmaceutical.